Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tie-Up With MedImmune Marks Catalyst's Second Partnership Deal In A Week

This article was originally published in The Pink Sheet Daily

Executive Summary

The collaboration involves discovery work on undisclosed targets in the autoimmune and inflammatory disease areas.
Advertisement

Related Content

With Factor VIIa Tie-up, Wyeth And Catalyst Look To Take On Novo Nordisk
With Factor VIIa Tie-up, Wyeth And Catalyst Look To Take On Novo Nordisk
AstraZeneca Concentrates Biologics At MedImmune, Ups R&D

Topics

Advertisement
UsernamePublicRestriction

Register

PS069811

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel